Gram-Negative Bacteremia: Another Candidate for Switching from Intravenous to Oral Treatment?

In patients responding to an IV regimen, switching to oral treatment after 3–5 days had similar outcomes as continued IV therapy, provided certain criteria were met.

Switching from intravenous to oral antibiotic therapy can be as efficacious as continued IV treatment, even for infective endocarditis (NEJM JW Infect Dis Aug 28 2018 and N Engl J Med 2019; 380:415) or bone and joint infections (NEJM JW Infect Dis Jan 30 2019 and N Engl J Med 2019; 380:425), simplifying outpatient management. But what about gram-negative bacteremia, which is usually managed with a full course of IV antibiotics?

Researchers addressed this issue in a multicenter open-label, randomized trial involving 176 adults (mean age, 57) with gram-negative bloodstream infections. The source of bacteremia was most often the urinary tract (60%). Escherichia coli (67%) and Klebsiella spp. (24%) were the most prevalent pathogens. Of the teste…

Reviewing Author

Thomas Glück, MD

Disclosures

Editorial BoardsConsilium Infectiorum by InfectoPharm, Infection

Thomas Glück, MD

Disclosures

Editorial BoardsConsilium Infectiorum by InfectoPharm, Infection

Gram-Negative Bacteremia: Another Candidate for Switching from Intravenous to Oral Treatment?

Topics

Reviewing Author